Serum leptin level can be a negative marker of hepatocyte damage in nonalcoholic fatty liver

Journal of Gastroenterology

Volumn 38, Issue 5, 2003, Pages 471-476

  Serin, Ender ^a   Özer, Birol ^a   Gümürdülü, Yüksel ^a   Kayaselçuk, Fazilet ^a   Kul, Kemal ^a   Boyacioǧlu, Sedat ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Insulin resistance; Leptin; Non alcoholic fatty liver; Serum transaminase

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CREATININE; INSULIN; LEPTIN; NITROGEN; UREA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FATTY LIVER; FEMALE; HUMAN; INSULIN RESISTANCE; LIVER CELL DAMAGE; LIVER NECROSIS; LOGISTIC REGRESSION ANALYSIS; MALE; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; ULTRASOUND; UREA NITROGEN BLOOD LEVEL;

ADULT; BIOLOGICAL MARKERS; BODY MASS INDEX; DISEASE PROGRESSION; FATTY LIVER; FATTY LIVER, ALCOHOLIC; FEMALE; HEPATOCYTES; HUMANS; INSULIN RESISTANCE; LEPTIN; LOGISTIC MODELS; MALE; MIDDLE AGED; OBESITY;

EID: 0038724201     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00535-002-1084-5     Document Type: Article

References (25)

1. Yngve FY, Arthur JM, Zobair MY, Giulio M. Clinical features and natural history of non-alcoholic steatosis syndromes. Semin Liver Dis 2001;21:17-26.
2. Marchesini G, Brizi M, Morselli-Labata AM, Bianchi G, Bugianesi E, McCullough AJ, et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 1999;107: 450-5.
3. Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001;120:1183-92.
4. Day CP, James OFW. Steatohepatitis: a tale of two "hits"? Gastroenterology 1998;114:842-5.
5. James O, Day C. Non-alcoholic steatohepatitis: another disease of affluence. Lancet 1999;353:1634-6.
6. Lee KM. Leptin, obesity and liver disease. Gastroenterology 1998;115:997-1001.
7. Cohen B, Novick D, Rubinstein M. Modulation of insulin activities by leptin. Science 1996;274:1185-8.
8. Loffreda S, Yang SQ, Lin HZ, Karp CL, Brengman ML, Wang DJ, et al. Leptin regulates proinflammatory immune responses. FASEB J 1998;12:57-65.
9. Potter JJ, Womack L, Mezey E, Anania FA. Transdifferentiation of rat hepatic stellate cells results in leptin expression. Biochem Biophys Res Commun 1998;244:178-82.
10. Cortez-Pinto H, Camilo ME, Baptista A, De Oliviera AG, De Moura MC. Non-alcoholic fatty liver: another feature of the metabolic syndrome? Clin Nutr 1999;18:353-8.
11. Giannini E, Botta F, Cataldi A, Tenconi GL, Ceppa P, Barreca T, et al. Leptin levels in nonalcoholic steatohepatitis and chronic hepatitis C. Hepatogastroenterology 1999;46:2422-5.
12. Uygun A, Kadayifçi A, Yeşilova Z, Erdil A, Yaman H, Saka M, et al. Serum leptin levels in patients with nonalcoholic steatohepatitis. Am J Gastroenterol 2000;95:3584-9.
13. Clark JM, Brancati FL, Diehl AM. Nonalcoholic fatty liver disease. Gastroenterology 2002;122:1649-57.
14. Dixon JB, Bhathal PS, O'Brien PE. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001;121:91-100.
15. Obesity: preventing and managing the global epidemic. Report of a WHO consultation on obesity. World Health Organ Tech Rep Ser 2000;894:i-xii, 1-253.
16. Galvin P, Ward G, Walteers J, Pestell R, Koschman M, Vaag A, et al. A simple method for quantitation of insulin sensitivity and insulin release from an intravenous glucose tolerance test. Diabet Med 1992;9:921-8.
17. Muller G, Ertl J, Gerl M, Preibisch G. Leptin impairs metabolic actions of insulin in isolated rat adipocytes. J Biol Chem 1997; 272:10585-93.
18. Sivitz WI, Walsh SA, Morgan DA, Thomas MJ, Haynes WG. Effects of leptin on insulin sensitivity in normal rats. Endocrinology 1997;138:3395-401.
19. O'Rourke L, Yeaman SJ, Shepherd PR. Insulin and leptin acutely regulate cholesterol ester metabolism in macrophages by novel signaling pathways. Diabetes 2001;50:955-61.
20. Bouloumie A, Marumo T, Lafontan M, Busse R. Leptin induces oxidative stress in human endothelial cells. FASEB J 1999;13: 1231-8.
21. Zhang HH, Kumar S, Barnett AH, Eggo MC. Tumor necrosis factor α exerts dual effects on human adipose leptin synthesis and release. Mol Cell Endocrinol 2000;159:79-88.
22. Langhans W. Anorexia of infection: current prospects. Nutrition 2000;16:996-1005.
23. Leiningeer MT, Portocarrero CP, Bidwell CA, Spurlock ME, Houseknecht KL. Leptin expression is reduced with acute endotoxemia in the pig: correlation with glucose, insulin, and insulin-like growth factor-1 (IGF-1). J Interferon Cytokine Res 2000;20:99-106.
24. Arnalich F, Lopez J, Codoceo R, Jimnez M, Madero R, Montiel C. Relationship of plasma leptin to plasma cytokines and human survival in sepsis and septic shock. J Infect Dis 1999;180:908-11.
25. Ikejima K, Honda H, Yoshikawa M, Hirose M, Kitamura T, Takei Y, et al. Leptin augments inflammatory and profibrogenic responses in the murine liver induced by hepatotoxic chemicals. Hepatology 2001;34:288-97.